{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["31(9)"],"submitter":["Tranby EP"],"pubmed_abstract":["<h4>Background</h4>This study compared prevalence, incidence, mortality rates, treatment costs, and risk factors for oral and oropharyngeal cancer (OC/OPC) between two large United States adult cohorts in 2012-2019.<h4>Methods</h4>Medicaid and commercial claims data came from the IBM Watson Health MarketScan Database. Logistic regression analyses estimated incidence and risk factors for OC/OPC. Mortality was calculated by merging deceased individuals' files with those of the existing cancer cohort. Summing costs of outpatient and inpatient services determined costs.<h4>Results</h4>Prevalence of OC/OPC in Medicaid enrollees decreased each year (129.8 cases per 100,000 enrollees in 2012 to 88.5 in 2019); commercial enrollees showed a lower, more stable prevalence (64.7 per 100,000 in 2012 an"],"journal":["Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"],"pagination":["1849-1857"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9437560"],"repository":["biostudies-literature"],"pubmed_title":["Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data."],"pmcid":["PMC9437560"],"pubmed_authors":["Frantsve-Hawley J","Tranby EP","Backley M","Tomar SL","Fager GL","Heaton LJ","Kelly AL"],"additional_accession":[]},"is_claimable":false,"name":"Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data.","description":"<h4>Background</h4>This study compared prevalence, incidence, mortality rates, treatment costs, and risk factors for oral and oropharyngeal cancer (OC/OPC) between two large United States adult cohorts in 2012-2019.<h4>Methods</h4>Medicaid and commercial claims data came from the IBM Watson Health MarketScan Database. Logistic regression analyses estimated incidence and risk factors for OC/OPC. Mortality was calculated by merging deceased individuals' files with those of the existing cancer cohort. Summing costs of outpatient and inpatient services determined costs.<h4>Results</h4>Prevalence of OC/OPC in Medicaid enrollees decreased each year (129.8 cases per 100,000 enrollees in 2012 to 88.5 in 2019); commercial enrollees showed a lower, more stable prevalence (64.7 per 100,000 in 2012 an","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-04T21:04:17.188Z","creation":"2025-04-04T21:04:17.188Z"},"accession":"S-EPMC9437560","cross_references":{"pubmed":["35732291"],"doi":["10.1158/1055-9965.EPI-22-0114"]}}